Anzahl der Publikationen: 1
	Zeitschriftenartikel
    Casulo, Carla  ORCID: https://orcid.org/0000-0003-4998-9932; Dixon, Jesse G.; Le-Rademacher, Jennifer
ORCID: https://orcid.org/0000-0003-4998-9932; Dixon, Jesse G.; Le-Rademacher, Jennifer  ORCID: https://orcid.org/0000-0002-2234-7430; Hoster, Eva
ORCID: https://orcid.org/0000-0002-2234-7430; Hoster, Eva  ORCID: https://orcid.org/0000-0002-0749-1389; Hochster, Howard S.
ORCID: https://orcid.org/0000-0002-0749-1389; Hochster, Howard S.  ORCID: https://orcid.org/0000-0002-9893-1529; Hiddemann, Wolfgang; Marcus, Robert; Kimby, Eva; Herold, Michael; Sebban, Catherine; Gyan, Emmanuel
ORCID: https://orcid.org/0000-0002-9893-1529; Hiddemann, Wolfgang; Marcus, Robert; Kimby, Eva; Herold, Michael; Sebban, Catherine; Gyan, Emmanuel  ORCID: https://orcid.org/0000-0002-7651-9189; Foon, Kenneth; Nielsen, Tina; Vitolo, Umberto
ORCID: https://orcid.org/0000-0002-7651-9189; Foon, Kenneth; Nielsen, Tina; Vitolo, Umberto  ORCID: https://orcid.org/0000-0001-7772-2747; Salles, Gilles A.
ORCID: https://orcid.org/0000-0001-7772-2747; Salles, Gilles A.  ORCID: https://orcid.org/0000-0002-9541-8666; Shi, Qian und Flowers, Christopher R.
  
(2022):
		Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
	
	 In: Blood, Bd. 139, Nr.  11: S. 1684-1693
ORCID: https://orcid.org/0000-0002-9541-8666; Shi, Qian und Flowers, Christopher R.
  
(2022):
		Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
	
	 In: Blood, Bd. 139, Nr.  11: S. 1684-1693
	
      
        
      
 
		Diese Liste wurde am 
				Sun Oct 26 00:26:11 2025 CEST
			 erstellt.